Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - Micardis Plus(R) - Pharmakologie (14 Abbildungen)
Übersicht


Zum ersten Bild Abb. 6: Angiotensin-I-Rezeptorblocker - Verteilungsvolumina Abb. 7: Telmisartan - PPAR-Gamma Abb. 8: SBD - DBD Aktuelles Bild - Abb. 9: Normaldosierung Abb. 10: Dosierung - Alter - Geschlecht Abb. 11: Telmisartan - Harnausscheidung Abb. 12: Dosierung - Nephropathien Zum letzten Bild
Abbildung 9: Normaldosierung
Telmisartan produces substantial antihypertensive efficacy with a dose of 40 mg, and so this is the recommended starting dose.1,2 Further blood pressure reductions can be achieved with the 80 mg dose.1,2 If additional blood-pressure lowering power is needed, telmisartan can be given in fixed-dose combination with the diuretic HCTZ. Blood pressure reductions are achieved smoothly but quickly, with most of the response apparent within 2 weeks.1,2 1. Micardis Prescribing Information. Available at http://www.bidocs.com/renetnt:/Prescribing+Information/PIs/Micardis+Tabs/MICARDIS20-40-80 mg.PDF 2. Micardis Summary of Product Characteristics. Available at http://www.emea.eu.int/humandocs/Humans/EPAR/Micardis/Micardis.htm
 
Normaldosierung
Vorheriges Bild Nächstes Bild   


Abbildung 9: Normaldosierung
Telmisartan produces substantial antihypertensive efficacy with a dose of 40 mg, and so this is the recommended starting dose.1,2 Further blood pressure reductions can be achieved with the 80 mg dose.1,2 If additional blood-pressure lowering power is needed, telmisartan can be given in fixed-dose combination with the diuretic HCTZ. Blood pressure reductions are achieved smoothly but quickly, with most of the response apparent within 2 weeks.1,2 1. Micardis Prescribing Information. Available at http://www.bidocs.com/renetnt:/Prescribing+Information/PIs/Micardis+Tabs/MICARDIS20-40-80 mg.PDF 2. Micardis Summary of Product Characteristics. Available at http://www.emea.eu.int/humandocs/Humans/EPAR/Micardis/Micardis.htm
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung